Dr Anjana Karunakaran is a Specialist Ophthalmologist with five years of experience. She completed her MBBS from Government Medical College, Trivandrum (2007). She received her MD in Ophthalmology from the prestigious All India Institute of Medical Sciences (2015), and she went on to pursue a Fellowship in Cornea and Refractive Surgery from Narayana Nethralaya ,Bangalore (2018). She worked as Cornea Refractive Surgeon in Chaithanya Eye Hospital and Research Institute, Trivandrum, India, for four years before joining Medeor Hospital, Dubai. She has expertise in comprehensive ophthalmology, both anterior segment and posterior segment. She deals with ocular emergencies and trauma.
Dr. Mehdi Afrit is a Medical Oncologist who practices at Burjeel Specialty Hospital in Sharjah. He has over 11 years of experience caring for and managing cancer patients. He has extensive experience providing chemotherapy, hormonal therapy, immunotherapy, and targeted therapy to patients. He earned a Certificate of Medical Oncology from the Gustave Roussy Institute in Paris, France, where he received training in antitumor chemotherapy and cancer medical treatment. Additionally, he holds an international certificate in breast diseases. He also has a certificate in Good Clinical Practice from Trans Celerate Biopharma Inc. and a certificate in Clinical Trial Management: Good Clinical Practice from the Faculty of Pharmaceutical Medicine of the Royal College of Physicians. He previously worked for over five years as an Assistant Professor of Medical Oncology at Tunis’s Faculty of Medicine. He later practiced as a Consultant, Medical Oncologist for six years at Arianna’s hospital in Tunisia. He later worked for two years as a Specialist Medical Oncologist at Zulekha Hospital. He was also an investigator in three international clinical trials and holds clinical trial auditing and CRO certifications and a GCP Training Certificate from 2016. He is a member in good standing of the Emirates Oncology Society (EOS), the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). His clinical expertise includes but is not limited to the following: